Nivesh Mittal

745 citations
7 papers · 582 indexed · h-index 6

Nivesh Mittal

7 papers receiving 570 citations

Peers

Nivesh Mittal
Comparison fields: 5 of 77
  • Pharmaceutical Science 165
  • Biomaterials 283
  • Molecular Medicine 28
  • Biomedical Engineering 161
  • Molecular Biology 241
Replace Pavan Balabathula with:
Pavan Balabathula United States
Bivash Mandal United States
Evren Gündoğdu Türkiye
Rohan Lalani India
Farnaz Esmaeili Iran
Rongli Zhao China
Valamla Bhavana India
Tushar Date India
Himanshu Bhattacharjee United States
Gitu Pandey India
Nivesh Mittal relative to Pavan Balabathula United States Pavan Balabathula's profile →
Citations per field
00.5×1.5×
Pavan Balabathula · 1×
Citations per year

Countries citing papers authored by Nivesh Mittal

Since Specialization
Citations

This map shows the geographic impact of Nivesh Mittal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nivesh Mittal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nivesh Mittal more than expected).

Fields of papers citing papers by Nivesh Mittal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nivesh Mittal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nivesh Mittal. The network helps show where Nivesh Mittal may publish in the future.

Co-authorship network

The 11 scholars most cited alongside Nivesh Mittal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nivesh Mittal Line = papers co-authored together Nivesh Mittal links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1 202017
2 20185
3 2015146
4 201411
5 20138
6 2012369
7 201226

About Nivesh Mittal

Nivesh Mittal is a scholar working on Biomaterials, Pharmaceutical Science, Infectious Diseases, Hematology and Oncology, having authored 7 papers that have together received 582 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (4 papers), RNA Interference and Gene Delivery (3 papers), Antifungal resistance and susceptibility (2 papers), Cancer therapeutics and mechanisms (1 paper), Peptidase Inhibition and Analysis (1 paper), Immunotherapy and Immune Responses (1 paper), Plant-Microbe Interactions and Immunity (1 paper) and Cholinesterase and Neurodegenerative Diseases (1 paper). The work is most often cited by research in Pharmaceutical Science (165 citations), Biomaterials (283 citations), Molecular Medicine (28 citations), Biomedical Engineering (161 citations) and Molecular Biology (241 citations). Nivesh Mittal has collaborated with scholars based in United States and South Korea. Frequent co-authors include Pavan Balabathula, G. Christopher Wood, Bivash Mandal, Laura Thoma, Himanshu Bhattacharjee, Hongkee Sah, Dileep R. Janagam, Sarah Whaley, P. David Rogers and Saini Setua. Their work appears in journals such as Pharmaceutics, European Journal of Pharmaceutical Sciences, Nanomedicine Nanotechnology Biology and Medicine, Journal of Fluorescence and Journal of drug targeting.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026